Our Firm is representing numerous women in this proceeding who allegedly suffered serious vaginal mesh complications due to Ethicon devices.
New York, New York (PRWEB) August 10, 2014
Transvaginal mesh lawsuits (http://www.transvaginalmeshlawsuithelp.com/) filed against Johnson & Johnson’s Ethicon, Inc. unit continue to move forward in the federal litigation underway in U.S. District Court, Southern District of West Virginia, Bernstein Liebhard LLP reports. According to an Order issued on August 4, 2014, the Court will convene a pretrial conference for the litigation’s second round of bellwether trials on August 13, 2014 at 1:00 p.m. The second bellwether trial will begin on August 25, 2014, with jury selection to begin on August 22nd. (In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2327)
“Our Firm is representing numerous women in this proceeding who suffered serious allegedly vaginal mesh complications due to Ethicon devices. We are looking forward to this bellwether trial, as its outcome may provide insight into how juries could rule in similar cases,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to investigate transvaginal mesh lawsuits on behalf of women who suffered serious injuries, allegedly due to products marketed by Ethicon and other manufacturers.
Transvaginal Mesh Litigation
Court documents indicate that nearly 20,000 transvaginal mesh lawsuits have been filed against Ethicon in the federal litigation, where Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving on the Plaintiffs’ Steering Committee. All of the lawsuits claim that the company’s pelvic mesh devices caused recipients to suffer serious vaginal mesh complications, including chronic pain, mesh erosion, and organ damage. Plaintiffs further allege that the devices were defectively designed and inadequately tested, and that Ethicon did not provide doctors and patients with appropriate warnings regarding their risks.
Mr. Grand is also a member of the Plaintiffs’ Steering Committee for several other consolidated litigations underway in the Southern District of West Virginia, including those involving: American Medical Systems, Inc. (MDL No. 2325); Boston Scientific Corp., (MDL No. 2326); and C.R. Bard, Inc., (MDL No. 2187).
In addition to his work on the federal vaginal mesh litigations, Mr. Grand has also been appointed Co-Liaison Counsel in two proceedings involving Ethicon and C.R. Bard that are currently moving forward in New Jersey’s Atlantic County Superior Court. He was a member of the Plaintiff’s trial team for the first trial in the Ethicon proceeding, which ended in March 2013 with a jury awarding $11 million in compensatory and punitive damages to a woman who suffered vaginal mesh complications related to the Ethicon Gynecare Prolift device. ((In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)
According to court documents, the transvaginal mesh litigations pending in state and federal court have been building since October 2008, when the U.S. Food & Drug Administration (FDA) alerted the public to the serious risks associated with the devices. In July 2011, the agency issued a second alert after it received thousands of additional reports of injuries associated with transvaginal mesh. This past April, the FDA proposed reclassifying vaginal mesh used to treat pelvic organ prolapse as high-risk medical devices, which would subject the devices to greater regulatory scrutiny.
Alleged victims of serious vaginal mesh complications may be able to pursue their own legal claim against the manufacturer of their device. To learn more about the ongoing transvaginal mesh litigation, please visit Bernstein Liebhard LLP's website or the Firm's Facebook page: https://www.facebook.com/meshlawsuit. To obtain a free, confidential and no-obligation case review, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP